Taysha Gene Therapies, Inc. ($TSHA)
Filing Information
| Accession Number | 0001793412-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 27, 2026 |
| Document Date | Jan 23, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
102,817
Total Value
$485,041.89
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jan 23, 2026 | Sale | 78,968 | $4.75 | $375,098.00 | 1,467,635 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jan 26, 2026 | Sale | 23,849 | $4.61 | $109,943.89 | 1,443,786 | Direct | โ | View Details |